“In the first quarter, Runway Growth focused on the close and integration of the SWK Holdings acquisition, while navigating a volatile macroeconomic backdrop,” said David Spreng, Founder and CEO of Runway Growth. “With the transaction now complete, we are well positioned to selectively capitalize on opportunities and expand our exposure to leading healthcare and life sciences companies. Today, we also announced a new $15 million share repurchase authorization, which we expect to utilize as we believe our shares present an extremely compelling value relative to the outlook of the business.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RWAY:
- Runway Growth Finance names Avisha Khubani as Chief Credit Officer
- Runway Growth Finance Declares Second-Quarter 2026 Cash Dividend
- Runway Growth Completes SWK Acquisition, Expands Healthcare Focus
- Runway Growth Finance price target lowered to $10 from $12 at B. Riley
- Runway Growth Finance price target lowered to $7 from $10 at Wells Fargo